title: [Real-Life Evaluation of the Compact Program for Smoking Cessation].
abstract: Smoking cessation as a therapeutic intervention has largely not the significance that it should have according to its potential influence on diseases in the pulmonary practice. Barriers against smoking cessation apart from the addiction character of tobacco dependence are mainly the almost complete absence of reimbursement as well as concerns regarding low achievable long-term abstinence. The presented study shows that despite these barriers smoking cessation in pulmonology practice is successful if carried out by using a 2-step motivation of the participants. The long-term abstinence success of 46 % after 12 months (point prevalence) presented here was achieved with the use of behavioral therapy and medical support. Success factors are doctor's office setting and consequent information and encouragement for medical support (mostly varenicline).
authors.affiliation: Lungenarztpraxis Tegel, Berlin.
authors.forename: T
authors.initials: T
authors.lastname: Hering
authors.affiliation: MedWiss GmbH, Weinitzen, Österreich.
authors.forename: J
authors.initials: J
authors.lastname: Andres
authors.affiliation: Lungenarztpraxis Tegel, Berlin.
authors.forename: H-J
authors.initials: HJ
authors.lastname: Ruhr
authors.affiliation: Lungenarztpraxis Tegel, Berlin.
authors.forename: K
authors.initials: K
authors.lastname: Berkling
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001521:Behavior Therapy / Q000706:statistics & numerical data; D003131:Combined Modality Therapy / Q000379:methods / Q000706:statistics & numerical data; D005260:Female; D005858:Germany / Q000453:epidemiology; D006293:Health Promotion / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D015397:Program Evaluation; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology*; D016540:Smoking Cessation / Q000379:methods / Q000706:statistics & numerical data*; D000074606:Smoking Prevention; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000453:epidemiology* / Q000517:prevention & control*; D016896:Treatment Outcome; D000068580:Varenicline / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000068580:Varenicline